Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis has short- and long-term benefits: a single-center study

AbstractObjectives Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation (TLPMA) is a minimally invasive alternative technique with low risk, fast recovery and few side effects. We aimed to evaluate the safety and long-term efficacy of TLPMA for treating adenomyosis.Methods...

Full description

Bibliographic Details
Main Authors: Yang Shunshi, Jueying Li, Jingjing Li, Lei Huang, Ying Chen, Xiaoyu Zhao, Hongxia Dong, Xiujuan Huang, Fen Yu, Xiong Li, Qinghua Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2023.2233713
_version_ 1797374236590866432
author Yang Shunshi
Jueying Li
Jingjing Li
Lei Huang
Ying Chen
Xiaoyu Zhao
Hongxia Dong
Xiujuan Huang
Fen Yu
Xiong Li
Qinghua Zhang
author_facet Yang Shunshi
Jueying Li
Jingjing Li
Lei Huang
Ying Chen
Xiaoyu Zhao
Hongxia Dong
Xiujuan Huang
Fen Yu
Xiong Li
Qinghua Zhang
author_sort Yang Shunshi
collection DOAJ
description AbstractObjectives Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation (TLPMA) is a minimally invasive alternative technique with low risk, fast recovery and few side effects. We aimed to evaluate the safety and long-term efficacy of TLPMA for treating adenomyosis.Methods We included 79 patients with symptomatic adenomyosis who underwent TLPMA and 44 patients with adenomyosis who received the levonorgestrel-releasing intrauterine system (LNG-IUS). We evaluated the role of laparoscopy in TLPMA as well as the short- and long-term effects of TLPMA.Results The mean age of the 79 patients who underwent TLPMA was 41.8 years. There was no difference in the mean age between the TLPMA and LNG-IUS groups. Laparoscopy could help to separate pelvic adhesions, provide a wide antenna path, and observe the uterine surface and bowel movement. No major complications were found in patients who underwent TLPMA. There was a significant post-treatment reduction in both the uterine and lesion volumes (p < 0.001). After a median follow-up duration of 36 months (range: 1–60 months), the uterine and lesion volumes remained stable. Additionally, most patients remained without dysmenorrhea, which confirms the long-term efficacy of TLPMA.Conclusions TLPMA is a feasible, minimally invasive technique for the treatment of adenomyosis, which significantly decreases the uterine and lesion volumes and has a good long-term effect.
first_indexed 2024-03-08T19:03:01Z
format Article
id doaj.art-9544c6e8fbac4d9aa0c93e255bcd4766
institution Directory Open Access Journal
issn 0265-6736
1464-5157
language English
last_indexed 2024-03-08T19:03:01Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Hyperthermia
spelling doaj.art-9544c6e8fbac4d9aa0c93e255bcd47662023-12-28T04:15:43ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572023-12-0140110.1080/02656736.2023.2233713Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis has short- and long-term benefits: a single-center studyYang Shunshi0Jueying Li1Jingjing Li2Lei Huang3Ying Chen4Xiaoyu Zhao5Hongxia Dong6Xiujuan Huang7Fen Yu8Xiong Li9Qinghua Zhang10Department of Ultrasound, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR ChinaDepartment of Ultrasound, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR ChinaDepartment of Ultrasound, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR ChinaDepartment of Obstetrics and Gynecology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR ChinaDepartment of Obstetrics and Gynecology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR ChinaDepartment of Ultrasound, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR ChinaDepartment of Ultrasound, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR ChinaDepartment of Ultrasound, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR ChinaDepartment of Ultrasound, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR ChinaDepartment of Obstetrics and Gynecology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR ChinaDepartment of Obstetrics and Gynecology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR ChinaAbstractObjectives Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation (TLPMA) is a minimally invasive alternative technique with low risk, fast recovery and few side effects. We aimed to evaluate the safety and long-term efficacy of TLPMA for treating adenomyosis.Methods We included 79 patients with symptomatic adenomyosis who underwent TLPMA and 44 patients with adenomyosis who received the levonorgestrel-releasing intrauterine system (LNG-IUS). We evaluated the role of laparoscopy in TLPMA as well as the short- and long-term effects of TLPMA.Results The mean age of the 79 patients who underwent TLPMA was 41.8 years. There was no difference in the mean age between the TLPMA and LNG-IUS groups. Laparoscopy could help to separate pelvic adhesions, provide a wide antenna path, and observe the uterine surface and bowel movement. No major complications were found in patients who underwent TLPMA. There was a significant post-treatment reduction in both the uterine and lesion volumes (p < 0.001). After a median follow-up duration of 36 months (range: 1–60 months), the uterine and lesion volumes remained stable. Additionally, most patients remained without dysmenorrhea, which confirms the long-term efficacy of TLPMA.Conclusions TLPMA is a feasible, minimally invasive technique for the treatment of adenomyosis, which significantly decreases the uterine and lesion volumes and has a good long-term effect.https://www.tandfonline.com/doi/10.1080/02656736.2023.2233713Adenomyosismicrowave ablationtransvaginal ultrasound and laparoscope
spellingShingle Yang Shunshi
Jueying Li
Jingjing Li
Lei Huang
Ying Chen
Xiaoyu Zhao
Hongxia Dong
Xiujuan Huang
Fen Yu
Xiong Li
Qinghua Zhang
Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis has short- and long-term benefits: a single-center study
International Journal of Hyperthermia
Adenomyosis
microwave ablation
transvaginal ultrasound and laparoscope
title Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis has short- and long-term benefits: a single-center study
title_full Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis has short- and long-term benefits: a single-center study
title_fullStr Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis has short- and long-term benefits: a single-center study
title_full_unstemmed Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis has short- and long-term benefits: a single-center study
title_short Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis has short- and long-term benefits: a single-center study
title_sort transvaginal ultrasound and laparoscopy guided percutaneous microwave ablation for adenomyosis has short and long term benefits a single center study
topic Adenomyosis
microwave ablation
transvaginal ultrasound and laparoscope
url https://www.tandfonline.com/doi/10.1080/02656736.2023.2233713
work_keys_str_mv AT yangshunshi transvaginalultrasoundandlaparoscopyguidedpercutaneousmicrowaveablationforadenomyosishasshortandlongtermbenefitsasinglecenterstudy
AT jueyingli transvaginalultrasoundandlaparoscopyguidedpercutaneousmicrowaveablationforadenomyosishasshortandlongtermbenefitsasinglecenterstudy
AT jingjingli transvaginalultrasoundandlaparoscopyguidedpercutaneousmicrowaveablationforadenomyosishasshortandlongtermbenefitsasinglecenterstudy
AT leihuang transvaginalultrasoundandlaparoscopyguidedpercutaneousmicrowaveablationforadenomyosishasshortandlongtermbenefitsasinglecenterstudy
AT yingchen transvaginalultrasoundandlaparoscopyguidedpercutaneousmicrowaveablationforadenomyosishasshortandlongtermbenefitsasinglecenterstudy
AT xiaoyuzhao transvaginalultrasoundandlaparoscopyguidedpercutaneousmicrowaveablationforadenomyosishasshortandlongtermbenefitsasinglecenterstudy
AT hongxiadong transvaginalultrasoundandlaparoscopyguidedpercutaneousmicrowaveablationforadenomyosishasshortandlongtermbenefitsasinglecenterstudy
AT xiujuanhuang transvaginalultrasoundandlaparoscopyguidedpercutaneousmicrowaveablationforadenomyosishasshortandlongtermbenefitsasinglecenterstudy
AT fenyu transvaginalultrasoundandlaparoscopyguidedpercutaneousmicrowaveablationforadenomyosishasshortandlongtermbenefitsasinglecenterstudy
AT xiongli transvaginalultrasoundandlaparoscopyguidedpercutaneousmicrowaveablationforadenomyosishasshortandlongtermbenefitsasinglecenterstudy
AT qinghuazhang transvaginalultrasoundandlaparoscopyguidedpercutaneousmicrowaveablationforadenomyosishasshortandlongtermbenefitsasinglecenterstudy